# Lisinopril and Hydrochlorothiazide

NDC: 70518-3505
Generic name: Lisinopril and Hydrochlorothiazide Tablets
Labeler / Manufacturer: REMEDYREPACK INC.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20220831

FDA application: ANDA076230

## Active ingredients

- HYDROCHLOROTHIAZIDE: 12.5 mg/1
- LISINOPRIL: 20 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70518-3505"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70518-3505
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3bea11a3-eb07-46b2-9b91-f8a48a2f3b7e